• Something wrong with this record ?

In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley

O. Soukup, J. Korabecny, D. Malinak, E. Nepovimova, NL. Pham, K. Musilek, M. Hrabinova, V. Hepnarova, R. Dolezal, P. Pavek, P. Jost, T. Kobrlova, J. Jankockova, L. Gorecki, M. Psotka, TD. Nguyen, K. Box, B. Outhwaite, M. Ceckova, A. Sorf, D. Jun, K. Kuca,

. 2018 ; 14 (3) : 281-292.

Language English Country Netherlands

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18033395

BACKGROUND: In the last decade, the concept of uncharged reactivators potentially able to penetrate the CNS has been introduced as an alternative to the classic charged oxime reactivators. However, this concept brings with it several associated drawbacks such as higher lipophilicity, difficulty in administration, lower affinity to cholinesterases, and higher toxicity risk. OBJECTIVE: In this study, we compare data obtained for a set of five classic charged reactivators and a set of three recently published uncharged oximes supplemented by two novel ones. METHODS: This time, we used only in silico prediction and in vitro approaches. RESULTS: Our data showed that tested uncharged oximes have low affinity for cholinesterases, do not possess high reactivation potency, and certainly represent a greater toxicity risk due to higher lipophilicity. We assume that balanced physicochemical properties will be required for the successful treatment of OP poisoning. Nevertheless, the compound meeting such criteria and pinpointed in silico (K1280) failed in this particular case. CONCLUSION: From the presented data, it seems that the concept of uncharged reactivators will have to be modified, at least to improve the bioavailability and to satisfy requirements for in vivo administration.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033395
003      
CZ-PrNML
005      
20221101094722.0
007      
ta
008      
181008s2018 ne f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1573406414666180112105657 $2 doi
035    __
$a (PubMed)29332594
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Soukup, Ondrej $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
245    10
$a In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley / $c O. Soukup, J. Korabecny, D. Malinak, E. Nepovimova, NL. Pham, K. Musilek, M. Hrabinova, V. Hepnarova, R. Dolezal, P. Pavek, P. Jost, T. Kobrlova, J. Jankockova, L. Gorecki, M. Psotka, TD. Nguyen, K. Box, B. Outhwaite, M. Ceckova, A. Sorf, D. Jun, K. Kuca,
520    9_
$a BACKGROUND: In the last decade, the concept of uncharged reactivators potentially able to penetrate the CNS has been introduced as an alternative to the classic charged oxime reactivators. However, this concept brings with it several associated drawbacks such as higher lipophilicity, difficulty in administration, lower affinity to cholinesterases, and higher toxicity risk. OBJECTIVE: In this study, we compare data obtained for a set of five classic charged reactivators and a set of three recently published uncharged oximes supplemented by two novel ones. METHODS: This time, we used only in silico prediction and in vitro approaches. RESULTS: Our data showed that tested uncharged oximes have low affinity for cholinesterases, do not possess high reactivation potency, and certainly represent a greater toxicity risk due to higher lipophilicity. We assume that balanced physicochemical properties will be required for the successful treatment of OP poisoning. Nevertheless, the compound meeting such criteria and pinpointed in silico (K1280) failed in this particular case. CONCLUSION: From the presented data, it seems that the concept of uncharged reactivators will have to be modified, at least to improve the bioavailability and to satisfy requirements for in vivo administration.
650    _2
$a zvířata $7 D000818
650    _2
$a antidota $x chemická syntéza $x farmakologie $x toxicita $7 D000931
650    _2
$a hematoencefalická bariéra $x účinky léků $7 D001812
650    _2
$a butyrylcholinesterasa $x metabolismus $7 D002091
650    _2
$a cholinesterasové inhibitory $x chemická syntéza $x farmakologie $x toxicita $7 D002800
650    _2
$a reaktivátory cholinesterasy $x chemická syntéza $x farmakologie $x toxicita $7 D002801
650    _2
$a počítačová simulace $7 D003198
650    _2
$a myši $7 D051379
650    _2
$a otrava organofosfáty $x farmakoterapie $7 D062025
650    _2
$a organofosfáty $x toxicita $7 D010755
650    _2
$a oximy $x chemická syntéza $x farmakologie $x toxicita $7 D010091
650    _2
$a paraoxon $x toxicita $7 D010261
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a sarin $x toxicita $7 D012524
655    _2
$a časopisecké články $7 D016428
700    1_
$a Korabecny, Jan $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Malinak, David $u Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Nepovimova, Eugenie $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Pham, Ngoc L $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Musilek, Kamil $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Hrabinova, Martina $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Hepnarova, Vendula $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Dolezal, Rafael $u Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Pavek, Petr $u Department of Pharmacology and Toxicology Pharmaceutical Faculty, Charles University, Heyrovskeho 1203, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Jost, Petr $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Kobrlová, Tereza, $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. $d 1991- $7 xx0277928
700    1_
$a Jankockova, Jana $u Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Górecki, Lukáš $7 xx0243228 $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Psotka, Miroslav $u Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. $7 xx0277934
700    1_
$a Nguyen, Thuy D $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Box, Karl $u Sirius Analytical Ltd, Forest Row, East Sussex, United Kingdom.
700    1_
$a Outhwaite, Breeze $u Sirius Analytical Ltd, Forest Row, East Sussex, United Kingdom.
700    1_
$a Ceckova, Martina $u Department of Pharmacology and Toxicology Pharmaceutical Faculty, Charles University, Heyrovskeho 1203, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Sorf, Ales $u Department of Pharmacology and Toxicology Pharmaceutical Faculty, Charles University, Heyrovskeho 1203, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Jun, Daniel $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Kuca, Kamil $u Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
773    0_
$w MED00180387 $t Medicinal chemistry $x 1875-6638 $g Roč. 14, č. 3 (2018), s. 281-292
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29332594 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20221101094718 $b ABA008
999    __
$a ok $b bmc $g 1339447 $s 1030389
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 14 $c 3 $d 281-292 $i 1875-6638 $m Medicinal chemistry $n Med Chem $x MED00180387
LZP    __
$a Pubmed-20181008

Find record

Citation metrics

Archiving options